僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Tibulizumab （LY 3090106） is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor （BAFF） and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research